During Pride Month, we owe it to history to recall an embarrassing, tragic twist in the relationship between AIDS activism and the medical marijuana movement.
Archive for month: June, 2019
The historical account of Dennis Peron, the medical cannabis and human rights activist who was instrumental in bringing attention to AIDS and changing cannabis policy in California.
Findings suggest that CBD may have therapeutic potential to reduce binge eating and the development of obesity, according to a paper published by Addiction Biology.
On June 19 the House of Representatives voted to add the Blumenauer-McClintock Amendment —which would prevent the Department of Justice from enforcing federal law in states that have legalized adult-use marijuana—to an appropriations bill.
Oncotarget, 25 June 2019
The Cannabis plant contains over 100 phytocannabinoids and hundreds of other components. The biological effects and interplay of these Cannabis compounds are not fully understood and yet influence the plant’s therapeutic effects. Here we assessed the antitumor effects of whole…
“Medical Cannabis and Cannabinoids” is a peer-reviewed journal offering an international forum to present and discuss recent advances in the rapidly developing field of medical cannabis and cannabinoids.
Marijuana use is prevalent both in states where it is legal to some degree and in states where it is not. However, evidence suggests that many physicians may be unprepared for this reality.
There’s no official endorsement of medical cannabis for dementia, but with or without scientific data, more and more people are willing to investigate cannabis to treat their loved ones.
By Fred Gardner The International Cannabinoid Research Society (ICRS) has adopted the journal Cannabis and Cannabinoid Research (CCR) as its official publication. Dr. Daniele Piomelli, a pharmacologist at UC Irvine, edits the journal.
The press release from the publisher states that CCR is “extremely excited” by the affiliation. The release does not list clinical among the types of studies the ICRS has been “spearheading,” but does list “misuse potential.”
A note from the publisher of Alternative Therapies in Health and Medicine introduces “the first issue of Beyond CBD, a special supplement.” They’re obviously planning more. The lead article, “The Endocannabinoid System and its Modulation by Cannabidiol (CBD)” by Jamie Corroon, ND, MPH, and Jake F. Felice, ND, LMP is the most thorough and well-written overview we’ve seen.
Journal of Clinical Medicine, 5 June 2019
BACKGROUND: Chronic pain may be treated by medical cannabis. Yet, there is scarce evidence to support the role of medical cannabis in the treatment of fibromyalgia. The aim of the study was to investigate the characteristics, safety, and effectiveness of medical cannabis thera…
Current Treatment Options in Oncology, 3 June 2019
Cannabis is a useful botanical with a wide range of therapeutic potential. Global prohibition over the past century has impeded the ability to study the plant as medicine. However, delta-9-tetrahydrocannabinol (THC) has been developed as a stand-alone pharmaceutical initially …